MedPath

the comparison of glycemic control between sulfonylureas and repaglinide treated type 2 diabetic patients

Not Applicable
Recruiting
Conditions
type 2 diabetic patients
Registration Number
JPRN-UMIN000009541
Lead Sponsor
Yokohama City University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients using insulin 2) patients with severe liver dysfunction 3) pregnant women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath